Putnam Investments’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Putnam Investments’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-308,067	Closed	-$2.88M	–	1301
2016 Q4	$2.88M	Sell	308,067 -26,233	-8%	-$236K	0.01%	753
2016 Q3	$3.27M	Sell	334,300 -121,129	-27%	-$1.63M	0.01%	708
2016 Q2	$6.43M	Buy	455,429 +40,522	+10%	+$632K	0.02%	533
2016 Q1	$5.8M	Buy	414,907 +999	+0.2%	+$14.7K	0.01%	573
2015 Q4	$8.44M	Buy	413,908 +17,228	+4%	+$266K	0.02%	503
2015 Q3	$5.21M	Buy	396,680 +2,193	+0.6%	+$36.4K	0.01%	655
2015 Q2	$6.05M	Buy	394,487 +446	+0.1%	+$8.55K	0.01%	649
2015 Q1	$7.88M	Buy	394,041 +59,541	+18%	+$1.33M	0.02%	607
2014 Q4	$7.03M	Hold	334,500	–	–	0.01%	639
2014 Q3	$6.22M	Buy	334,500 +150,000	+81%	+$2.72M	0.01%	682
2014 Q2	$4.26M	Buy	+184,500	New	+$3.25M	0.01%	833

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments's AGTC Position: Q1 2017 in Review

Putnam Investments sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2017, closing a stake of 308,067 shares — an estimated $2.88M sold.

Putnam Investments first reported a position in AGTC in Q2 2014 and held it in 11 quarters. The position peaked at $8.44M in Q4 2015. 89 funds tracked by Wall St. Rank hold AGTC as of Q1 2017.

Putnam Investments reported no remaining Applied Genetic Technologies Corporation position as of Q1 2017 after selling out during the quarter.
Putnam Investments sold 308,067 Applied Genetic Technologies Corporation shares in Q1 2017, an estimated $2.88M.
Putnam Investments first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 11 quarters.
Putnam Investments's Applied Genetic Technologies Corporation position peaked at $8.44M in Q4 2015.
89 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.